Diffusion Pharmaceuticals' CEO David Kalergis Interviewed

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Diffusion Pharmaceuticals' CEO David Kalergis Interviewed by The Life Sciences Report

SAN FRANCISCO, CA --(Marketwired - March 31, 2016) - It takes extraordinary dexterity to execute a strategic merger, and then to take first steps toward positioning a new molecular entity for a Phase 3 drug trial and potential partnership with a big pharma. That's exactly the inflection point at which Diffusion Pharmaceuticals Inc.  ( OTCQX : DFFN ) finds itself, says CEO David Kalergis. In this interview with The Life Sciences Report , Kalergis lays out Diffusion's plan for pivotal development of its treatment for primary brain cancer, which could drive the company's market cap to valuations that would bring huge upside to investors if successful.

The Life Sciences Report : David, let's talk about your clinical program. The Diffusion platform is designed to oxygenate tumor tissues with trans sodium crocetinate prior to conventional therapies. The hypothesis is that oxygenation of the tissues makes tumor cells more vulnerable to radiation and chemotherapy. Does this premise rest on the theory that tumor cells are a) more aggressive in a hypoxic environment, or b) that rapidly proliferating tumor cells are outrunning their blood supply, therefore making them less capable of receiving therapeutic agents via bloodstream?

David Kalergis : What we think is it's "b," which leads to "a." The inherent hypoxic nature of the tumor tissue outgrowing its blood supply then begins to select for more aggressive cells that have evolved to thrive in what would otherwise be an oxygen-deprived, hostile environment. That low-oxygen environment confers treatment resistance on these cancer cells. When you do not have a sufficient amount of free oxygen in the cell to support the killing power of radiation and chemo, those cells that have survived begin to thrive, and they evolve toward a...

Continue reading this interview: Diffusion Pharmaceuticals Takes Aim at Brain Cancer: CEO David Kalergis

About Streetwise Reports - The Life Sciences Report

Investors rely on The Life Sciences Report to share investment ideas for the biotech, pharmaceutical, medical device, and diagnostics industries. Our exclusive interviews with leading industry experts and analysts provide a clear picture of the causes of macro-economic shifts and the strategies that help you capitalize on developing trends.

DISCLOSURE:

Diffusion Pharmaceuticals Inc. is a sponsor of Streetwise Reports. David Kalergis had final approval of the content and is wholly responsible for the validity of the statements. Opinions expressed are the opinions of Mr. Kalergis and not of Streetwise Reports or its officers. The interview does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of information presented here is his or her own responsibility.

Please see Streetwise Reports' terms of use and full legal disclaimer .

Jim Patrick Email contact

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Knotch Bets Brands Need Answers, Not More Web Pages

Updated Category News Views 184

Pages are starting to look like expensive filing cabinets A website that cannot answer an agent may soon be expensive wallpaper. That is the blunt premise behind Knotch's Ace for Agents, launched Nov. 17, 2026, and frankly it lands because plenty of big companies have spent years piling pages atop pages until nobody can tell which claim is current. Knotch is pitching an...

Continue Reading
Voranigo Follow-Up Deepens the Glioma Care Debate Today

Updated Category News Views 159

Brain-tumor progress rarely arrives with a clean victory lap, but the longer INDIGO readout gives clinicians and sector watchers something sturdier than a one-time headline. Servier presented extended Phase 3 results for VORANIGO, or vorasidenib, at the Society for Neuro-Oncology meeting in Philadelphia on November 14 and 15, 2026. The central message is durable benefit...

Continue Reading
Airtel Money Upgrade Raises the Stakes in East Africa

Updated Category News Views 0

Mobile money lives or dies in the irritating little moments: a transfer that hangs, a menu that makes people punch five buttons too many, a merchant payment that simply will not clear. Airtel Money is attacking that friction in Malawi and Tanzania with an enhanced platform from Comviva, and this is more consequential than the usual software-refresh chest thumping. In...

Continue Reading
Caracal’s $200K VMI Pledge Targets Cadet Affordability

Updated Category News Views 197

A tuition award can still leave a brutal hole in the budget. That is the plain fact sitting underneath Caracal Products & Services’ $200,000 commitment to Virginia Military Institute. Federal ROTC scholarships can cover tuition, but VMI says room, board and quartermaster fees average about $15,000 annually. For a student who has done everything right—earned the ROTC...

Continue Reading
Max y Noelia Explore Trade at 9th CIIE in Shanghai

Updated Category News Views 126

Influencers at the Heart of Global Trade Exploration Makin' their debut on the big stage of the 9th China International Import Expo (CIIE), Mexican influencers Max y Noelia found themselves caught in a whirlwind of trade and cultural exchanges over in Shanghai. These digital mavens aren't just snapping selfies. Nope, they're capturing the very essence of international...

Continue Reading
Vusion's 2030 Plan Puts Recurring Revenue First At Scale

Updated Category News Views 20

Shelf labels are not exactly romance, yet Vusion has turned them into a serious growth machine. The 2030 plan is not really about hanging more electronic displays in aisles; it is about making those displays, sensors and store connections produce software and service revenue for years. That is the part of this story worth watching. The Hardware Base Is Becoming the Hook...

Continue Reading
Tim Hortons Bets on ELF Cheer for U.S. Holiday Visits

Updated Category News Views 0

Nothing says holiday restaurant marketing quite like putting spaghetti-shaped whipped topping on hot chocolate and trusting a 2003 movie to do the selling. Tim Hortons is rolling out an ELF-inspired menu at participating U.S. locations starting November 18, 2026, pairing the chain with Warner Bros. Consumer Products and mining Buddy the Elf's sugar-fueled world for a...

Continue Reading
Unisys Opens Its 2027 Innovation Program Across India

Updated Category News Views 147

Talent pipelines rarely make the market’s pulse race, but they can expose whether a tech firm is still trying to build for the next turn. Unisys has opened registration for the 2027 Unisys Innovation Program, its eighteenth annual technical competition for engineering students in India. For a company selling cloud, AI, digital workplace, applications and enterprise...

Continue Reading
Sectra's RSNA AI Pitch Centers on Workflow, Not Hype

Updated Category News Views 95

Radiology has heard enough grand AI promises to fill a hospital basement, which makes Sectra's RSNA 2026 message refreshingly grounded. The Swedish imaging IT and cybersecurity company is putting its weight behind the unglamorous part of adoption: fitting AI into the daily diagnostic machinery without handing clinicians another awkward system to babysit. That is where...

Continue Reading
Markel Elevates War Risk Expertise in London Market

Updated Category News Views 67

A Specialty Desk Gets Its Own Weather Vane War and political violence underwriting is not a corner of insurance where a fancy title change can be shrugged off. The ground shifts under the policyholder, the broker and the carrier without much warning, and a bad call can sit on a book for years. Markel Insurance has named Chloe Gordge Director of War and Political Violence...

Continue Reading

Top 5 Most Recently Viewed Articles

Aterian Prepares for Upcoming Earnings Call This Quarter

Updated Category News Views 141

Aterian's Upcoming Financial Results Announcement Aterian, Inc. (Nasdaq: ATER), a prominent player in the consumer products sector, is gearing up to reveal its financial performance for the second quarter. Scheduled for Wednesday in the coming week, this announcement will take place after market closure, providing investors with valuable insights into the company’s...

Continue Reading
Updated Disclosure Insights for Balanced Commercial Property Trust

Updated Category News Views 70

Understanding the Recent Disclosure from Rathbones Group Plc Regarding Balanced Commercial Property Trust Limited This article offers a crucial overview of the recent disclosure made by Rathbones Group Plc about its interests in Balanced Commercial Property Trust Limited. Grasping these disclosures is essential for investors who want to effectively maneuver through the...

Continue Reading
TerraVolta Resources Secures Major Funding for Lithium Project

Updated Category News Views 219

TerraVolta Resources Lands Major Funding for Lithium Initiative Exciting developments are unfolding in the critical minerals sector as TerraVolta Resources, LLC, a key player in this field, has been chosen to negotiate a substantial $225 million funding award from the U.S. Department of Energy (DOE). This funding is set to support the establishment of a groundbreaking...

Continue Reading
Shining Moments of Natural Diamonds at the Golden Globes

Updated Category News Views 142

Shining Moments of Natural Diamonds at the Golden Globes This year's Golden Globes red carpet was captivating, showcasing natural diamonds that enchanted audiences and attendees alike. Rather than adhering to the conventional white diamond look, celebrities embraced a vibrant palette of colored diamonds. This trend was not just about sparkle but deeply reflected...

Continue Reading
iQIYI Plans Major Offering of Convertible Senior Notes

Updated Category News Views 122

iQIYI Plans a Significant Offering of Convertible Senior Notes iQIYI, Inc. (Nasdaq: IQ) is making headlines with its recent announcement regarding a substantial offering. The company plans to issue $300 million in convertible senior notes, reflecting its ongoing commitment to strengthen its financial position and enhance shareholder value. Details of the Convertible...

Continue Reading